Gain Therapeutics (GANX)
NASDAQ:GANX
GANXGain Therapeutics
$9.00
-$0.152 (-1.66%)

Gain Therapeutics Stock Investors

Based on 455,589 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold GANX
On average, investors allocate 5.88% of their portfolios to GANX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 455,589 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding GANX

5.9%
Last 7
Days
20.3%
Last 30
Days
Percentages indicate the change in the number of portfolios holding GANX, out of 455,589 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

GANX Investor Activity

Currently, no data Available
Based on the activity of 38,796 investors who made their portfolios public
The table shows changes in GANX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

GANX Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
ANIXAnixa Biosciences
4.18%
-7.67%
7.54%
$127.29M
Healthcare
FLXNFlexion Therapeutics
4.04%
-1.71%
2.48%
$318.63M
Healthcare
LIFEaTyr Pharma
3.93%
-5.93%
-6.81%
$71.65M
Healthcare
SVRASavara
5.12%
-10.06%
-17.36%
$151.42M
Healthcare
AQSTAquestive Therapeutics
4.09%
-6.87%
-8.59%
$131.00M
Healthcare
GTBIFGreen Thumb Industries
8.28%
-2.11%
1.03%
$6.70B
Basic Materials
VLDRVelodyne Lidar
3.04%
-4.06%
-6.06%
$1.52B
Technology
BIDUBaidu
6.01%
-0.25%
2.92%
$60.00B
Technology
PINSPinterest
5.72%
2.31%
-2.12%
$48.98B
Technology
PLTRPalantir Technologies
9.25%
-3.81%
-8.33%
$41.00B
Technology
Based on the activity of 455,589 active portfolios
Open your Smart Portfolio

GANX Investor Analysis

GANX investors under 35

Under 35

100.0%
Last 30 days
Holdings Change
0.0%
of GANX holders
are under 35
Average Segment Performance
Monthly Return2.10%
Beta1.34
Dividend Yield9.16%
GANX investors between 35–55

Between 35–55

50.0%
Last 30 days
Holdings Change
33.3%
of GANX holders
are between 35–55
Average Segment Performance
Monthly Return2.25%
Beta1.57
Dividend Yield18.70%
GANX investors over 55

Over 55

0.2%
Last 30 days
Holdings Change
66.7%
of GANX holders
are over 55
Average Segment Performance
Monthly Return1.97%
Beta1.46
Dividend Yield20.39%
Overview of age group and performance of GANX stock investors
See who invests in GANX according to age group and performance.

Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
TSE:TRYPTryp Therapeutics Inc
TSE:MBCNMindBeacon Holdings, Inc.
MCURFMind Cure Health
HSTRFHollister Biosciences Inc
PHRRFNewscope Capital Corp.

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis